1. Home
  2. ITRM vs SPCB Comparison

ITRM vs SPCB Comparison

Compare ITRM & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • SPCB
  • Stock Information
  • Founded
  • ITRM 2015
  • SPCB 1988
  • Country
  • ITRM Ireland
  • SPCB Israel
  • Employees
  • ITRM N/A
  • SPCB N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • ITRM Health Care
  • SPCB Technology
  • Exchange
  • ITRM Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • ITRM 40.0M
  • SPCB 42.8M
  • IPO Year
  • ITRM 2018
  • SPCB N/A
  • Fundamental
  • Price
  • ITRM $0.68
  • SPCB $10.50
  • Analyst Decision
  • ITRM Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • ITRM 2
  • SPCB 1
  • Target Price
  • ITRM $7.00
  • SPCB $18.00
  • AVG Volume (30 Days)
  • ITRM 749.8K
  • SPCB 120.0K
  • Earning Date
  • ITRM 11-13-2025
  • SPCB 11-13-2025
  • Dividend Yield
  • ITRM N/A
  • SPCB N/A
  • EPS Growth
  • ITRM N/A
  • SPCB N/A
  • EPS
  • ITRM N/A
  • SPCB N/A
  • Revenue
  • ITRM N/A
  • SPCB $27,426,000.00
  • Revenue This Year
  • ITRM N/A
  • SPCB N/A
  • Revenue Next Year
  • ITRM $249.35
  • SPCB $29.31
  • P/E Ratio
  • ITRM N/A
  • SPCB $14.19
  • Revenue Growth
  • ITRM N/A
  • SPCB 2.90
  • 52 Week Low
  • ITRM $0.61
  • SPCB $2.81
  • 52 Week High
  • ITRM $3.02
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 43.17
  • SPCB 59.55
  • Support Level
  • ITRM $0.61
  • SPCB $9.40
  • Resistance Level
  • ITRM $0.76
  • SPCB $10.72
  • Average True Range (ATR)
  • ITRM 0.05
  • SPCB 0.51
  • MACD
  • ITRM 0.01
  • SPCB 0.16
  • Stochastic Oscillator
  • ITRM 49.65
  • SPCB 89.62

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: